EMEA-000717-PIP02-13-M02

Key facts

Invented name
Active substance
vigabatrin
Therapeutic area
Neurology
Decision number
P/0083/2017
PIP number
EMEA-000717-PIP02-13-M02
Pharmaceutical form(s)
Soluble tablet
Condition(s) / indication(s)
Treatment of epilepsy
Route(s) of administration
Oral use
Contact for public enquiries
Orphelia Pharma SA
France
E-mail: contact@orphelia-pharma.eu
Tel. +33 1427 70818
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000717-PIP02-13-M02
Compliance opinion date
21/07/2017
Compliance outcome
positive

Decision

How useful was this page?

Add your rating